Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series. Palumbo R, Licata L, Sottotetti F, Tagliaferri B, Pozzi E, Teragni C, Quaquarini E, Bernardo A Oncol Res Treat. 2018;41(1-2):8-13
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer. Martel S, Poletto E, Ferreira AR, Lambertini M, Sottotetti F, Bertolini I, Montemurro F, Bernardo A, Risi E, Zanardi E, Ziliani S, Mura S, Dellepiane C, Del Mastro L, Minisini AM, Puglisi F. Breast. 2018 Feb;37:142-147
Eribulin across multiple lines of chemotherapy: a retrospective study on quality of life and efficacy in metastatic breast cancer patients. Quaquarini E, Sottotetti F, D'Ambrosio D, Malovini A, Morganti S, Marinello A, Pavesi L, Frascaroli M.. Future Oncol. 2017 Apr;13(11s):11-23.
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study. Lambertini M, Ferreira AR, Di Meglio A, Poggio F, Puglisi F, Sottotetti F, Montemurro F, Poletto E, Bernardo A, Risi E, Dellepiane C, Sini V, Minuti G, Grasso D, Fancelli S, Del Mastro L.. Clin Breast Cancer. 2017 Dec;17(8):601-610.e2.
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life. Palumbo R, Sottotetti F, Trifirò G,Piazza E, Ferzi A, Gambaro A, Spinapolice GE, Pozzi E, Tagliaferri B, Teragni C, Bernardo A. Drug Design, Development and Therapy. 2015; 9:2189-2199.
Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians. Palumbo R, Sottotetti F, Riccardi A, Teragni C, Pozzi E, Quaquarini E, Tagliaferri B, Bernardo A. Ther Adv Med Oncol. 2013 Nov;5(6):334-50.
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. Strada MR, Palumbo R, Bernardo A, Riccardi A, Teragni C, Poggi G, Frascaroli M, Amatu A, Montagna B, Sottotetti F, Tagliaferri B, Bernardo G. Clin Breast Cancer. 2012 Feb;12(1):30-9
Acute thrombocytopenia: an unusual complication occurring after drug-eluting microspheres transcatheter hepatic chemoembolization. Poggi G, Quaretti P, Montagna B, Sottotetti F, Tagliaferri B, Pozzi E, Amatu A, Pagella C, Bernardo G.Cardiovasc Intervent Radiol. 2011 Feb;34 Suppl 2:S190-4. Epub 2010 Sep 18.
Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma. Poggi G, Montagna B, Melchiorre F, Quaretti P, Delmonte A, Riccardi A, Tagliaferri B, Sottotetti F, Di Cesare P, Stella MG, Villani L, Zorzetto M, Greco G, Cornalba G, Bernardo G. Anticancer Res. 2011 Nov;31(11):3927-33
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. Poggi G, Pozzi E, Riccardi A, Tonini S, Montagna B, Quaretti P, Tagliaferri B, Sottotetti F, Baiardi P, Pagella C, Minoia C, Bernardo G..Anticancer Res. 2010 Dec;30(12):5159-64.
